Michelle Mapes
About Michelle Mapes
Michelle S. Mapes (age 58) serves as Interim Principal Executive Officer (effective March 1, 2025) and Chief Legal & Administration Officer and Corporate Secretary at Green Plains (joined 2009; CL&AO since January 2018). She holds a JD, MBA, and BS in Accounting & Finance from the University of Nebraska–Lincoln . During 2024 she led legal support for strategic transactions (including Birmingham terminal sale), litigation resolution, investor engagement, and cost-savings post-GPP acquisition . Company performance context: 2024 EBITDA was $47.6m (down from $54.0m in 2023), with TSR value of a $100 investment at $61 in 2024 vs peer $142; longer-term TSR peaked in 2021–2022 then retrenched in 2024 .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Husch Blackwell LLP | Partner (renewable energy focus) | 2006–2009 | Specialized legal counsel in renewables, foundational to GPRE regulatory and transactional execution |
| HDM Corporation | Chief Administrative Officer & General Counsel | 2005–2006 | Leadership across administration and legal, relevant to enterprise risk/governance |
| Farm Credit Services of America | SVP – Corporate Services & General Counsel | 2000–2005 | Ag finance and corporate services experience, bolstering agricultural sector depth |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| National Feed & Grain Association | Board & Executive Committee | Current | Sector network, policy and industry insights |
| CFTC Agricultural Advisory Committee | Member | Current | Regulatory interface on ag/commodity markets |
Fixed Compensation
| Metric | 2022 | 2023 | 2024 | Notes |
|---|---|---|---|---|
| Base Salary ($) | 420,000 | 420,000 | 420,000 | Increased to $450,000 effective Mar 1, 2025 |
| Target Bonus % of Salary | — | — | 80% | Company-wide NEO target (ex-CEO) for 2024 |
| All Other Compensation ($) | 31,105 | 31,105 | 35,210 | Primarily 401(k) match and life insurance |
Additional 2025 update: Annual base salary set at $450,000 under her amended agreement (Feb 27, 2025) .
Performance Compensation
Annual Incentive (STIP) – 2024 Design and Outcome
| Metric | Weight | Threshold | Target | Max | 2024 Company Outcome | Individual Payout |
|---|---|---|---|---|---|---|
| “Emergent EBITDA” (corn oil, high-protein, clean sugar, FQT, Optimal) | 30% | Product targets | Product targets | Product targets (200%) | 2 of 5 sub-metrics achieved | 91% of target bonus for Mapes ($304,920) |
| Safety (OSHA, DART, permit deviations, training) | 5% | Set targets | Set targets | Set targets (200%) | Achieved 100% on all five initiatives | |
| Run Rate (mm bushels/yr) | 5% | 289 | 308 | 316 | — | |
| ESG – ISS Scoring | 2.5% | 3.00 | 2.67 | 2.33 | — | |
| Product yields (corn oil, protein, ethanol) | 5% | Set targets | Set targets | Set targets (200%) | Avg. 96% of target | |
| Other Operating Initiatives (quantitative) | 27.5% | Set per initiative | Set per initiative | Set per initiative (200%) | 4 of 7 achieved | |
| MBOs / Individual | 25% | Individual attainment | ||||
| STIP Payout Range | — | 50% (threshold) | 80% (NEOs) | 200% (NEOs) | Committee-certified | 91% for Mapes |
2024 bonus for Mapes: $304,920 (91% of $336,000 target) .
Long-Term Incentive (LTIP) – 2024 Grants and Structure
| Element | Grant Date | Shares | Grant-Date Fair Value ($) | Vesting | Performance Conditions |
|---|---|---|---|---|---|
| RSAs | 3/13/2024 | 12,915 | 300,015 | 1/3 each year on 3/13/25, 3/13/26, 3/13/27 | Service-based |
| PSUs | 3/14/2024 | 12,915 (target) | 300,015 (target) | Cliff vest in March 2027 | 3-year goals: absolute stock price ($30/$40/$50 for 50%/100%/200%), EBITDA (threshold/target +35%/max +80%), Protein/Sugar/Carbon ROI (threshold/target +25%/max +50%) |
Historical PSU payouts: 2022, 2023, and 2024 PSU cycles vested/are tracking at 150%, 123%, and 115% of target, respectively, for the cycles that reached vesting in 2022–2024 .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial Ownership | 91,512 shares (<1% of outstanding) as of April 11, 2025 |
| Ownership % | ≈0.13% (91,512 / 67,886,339 shares incl. warrants) based on shares outstanding reference |
| Unvested RSAs (12/31/2024) | 3/14/22: 3,724; 3/9/23: 5,770; 3/13/24: 12,915 |
| Unvested PSUs (12/31/2024) | 3/14/22: 11,173 (cliff 3/14/25); 3/9/23: 8,656 (cliff 3/9/26); 3/14/24: 12,915 (cliff March 2027) |
| 2024 Vesting/Withholding | 34,960 shares vested; tax withholdings on 2/16/24 (13,282), 3/8/24 (1,811), 3/14/24 (1,888) |
| Pledging/Hedging | Officers and directors prohibited from pledging, margin, short sales, derivatives, and hedging; company not aware of any pledges by NEOs/Board |
| Ownership Guidelines | CEO 6x salary; CFO 4x; other NEOs 3x salary; 3-year compliance window (directors 5x retainer) |
Vesting calendar likely to add supply into 2025–2027 via scheduled RSA tranches and PSU cliffs; however, trading is confined to open windows and subject to pre-clearance and ownership/retention policies, which mitigate immediate selling pressure .
Employment Terms
| Provision | Base Terms | Change-in-Control (CoC) Terms | Notes |
|---|---|---|---|
| Agreement | Employment agreement (Feb 3, 2020), amended Feb 27, 2025 | CoC Severance Plan (Aug 2023) | |
| Current Base | $450,000 (effective Mar 1, 2025) | — | Position to be eliminated no later than Dec 31, 2025 unless extended, with specified severance and equity treatment |
| Target Bonus | Participates in STIP; 2024 target 80% of salary | — | |
| Termination (no cause/good reason) | 6 months’ base salary; all outstanding equity vests (PSUs at target) | — | Good reason/”cause” aligned with standard definitions |
| CoC Severance | 2.5x base salary + 2.5x target bonus; up to 18 months health coverage; all equity fully vests (PSUs at target) | Double-trigger equity acceleration if awards assumed under plan; if not assumed, single-trigger vesting upon CoC per plan terms | |
| Clawback | Executive incentive compensation subject to SEC/Nasdaq 10D-1-compliant clawback policy (updated Nov 2023) | — | |
| Non-pledge/Hedging | Prohibited as noted above | — |
Potential payments table (company modeling as of 12/31/2024) implies Mapes’ aggregate value on a termination without cause/good reason of ~$744k and on CoC termination of ~$2.43m, inclusive of equity acceleration at target and health benefits assumptions .
Multi-Year Compensation (as reported)
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Salary ($) | 420,000 | 420,000 | 420,000 |
| Stock Awards ($) | 658,536 | 600,034 | 600,031 |
| Non-Equity Incentive Plan Comp ($) | 298,998 | 273,000 | 304,920 |
| All Other Compensation ($) | 31,105 | 31,105 | 35,210 |
| Total ($) | 1,408,639 | 1,324,139 | 1,360,161 |
Compensation Structure Notes (Alignment and Controls)
- Mix and metrics: 2024 NEO pay places a majority at-risk via STIP and LTIP; STIP tied to “Emergent EBITDA,” operating execution (yields, run-rate), safety, ESG (ISS), and MBOs; LTIP is 50% PSUs with forward-looking absolute price, EBITDA, and ROI goals and 50% RSAs .
- Governance and safeguards: Independent consultant (Pay Governance) advising since 2021; robust clawback; prohibitions on pledging/hedging; stock ownership/retention guidelines; no SERP; limited perquisites .
- Say-on-pay: 95% approval at 2024 annual meeting (reflecting investor support for design) .
Performance & Track Record (company context during Mapes’ leadership tenure)
| Year | TSR (Value of $100) | Peer TSR (Value of $100) | Net Loss ($000s) | EBITDA ($000s) |
|---|---|---|---|---|
| 2024 | 61 | 142 | (81,189) | 47,646 |
| 2023 | 163 | 175 | (76,299) | 54,031 |
| 2022 | 198 | 194 | (103,377) | 26,710 |
| 2021 | 225 | 277 | (44,146) | 116,795 |
| 2020 | 85 | 285 | (89,654) | (15,296) |
Execution contributions in 2024 specific to Mapes: legal support for strategic review, carbon initiatives and Birmingham terminal sale; litigation resolution; shareholder engagement; post-GPP integration savings .
Equity Vesting & Potential Selling Pressure (next 24–30 months)
- RSAs scheduled: 3/14/22 final tranche vests 3/14/25 (3,724 shares outstanding at 12/31/24); 3/9/23 tranches vest 3/9/25 and 3/9/26 (5,770 outstanding); 3/13/24 tranches vest 3/13/25, 3/13/26, 3/13/27 (12,915 outstanding) .
- PSUs scheduled (subject to performance certification): 3/14/22 (cliff 3/14/25; 11,173 target outstanding), 3/9/23 (cliff 3/9/26; 8,656 target), 3/14/24 (cliff March 2027; 12,915 target) .
- 2024 Form 4 activity per proxy: vest-driven share issuances with tax withholdings; proxy does not indicate open-market sales by Mapes in 2024 (additional Form 4s not reviewed here) .
Employment Terms (Retention and Transition)
- Feb 27, 2025 amendment: continues employment through no later than Dec 31, 2025; position will be eliminated unless extended; confirms base $450k and standard severance (6 months base) with full vesting of RSAs and PSUs at target upon separation under the amendment .
- Standard protections: six months’ salary on termination without cause/good reason; robust CoC double-trigger economics (2.5x salary and 2.5x target bonus, health benefits, full equity vesting) .
Investment Implications
- Alignment and incentives: Mapes’ pay is materially at-risk with explicit ties to execution levers (Emergent EBITDA, yields, safety, ESG, MBOs) and multi-year PSUs linked to absolute share price, EBITDA and high-value protein/sugar/carbon ROI—strong pay-for-performance alignment if strategic transformation delivers .
- Retention and transition risk: Her role is slated for elimination by year-end 2025 under the amendment, with predefined severance and equity vesting; this reduces retention risk near-term but increases leadership transition risk and creates identifiable vesting-related share supply windows through 2027 .
- Ownership and selling pressure: Beneficial ownership at ~0.13% of shares outstanding and a clear prohibition on pledging/hedging constrain misalignment risk; near-term vesting plus any separation-triggered acceleration could add stock supply, moderated by trading window and ownership/retention policies .
- Execution signal: 2024 bonus at 91% of target reflects strong individual/operational contributions amid mixed company results (EBITDA down; negative net income; weak 2024 TSR), suggesting the committee credited execution progress despite external/commodity headwinds .